Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

ClinicalTrials.gov ID: NCT01318733

Public ClinicalTrials.gov record NCT01318733. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 8:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of CD07805/47 Gel 0.5% Applied Topically Once Daily for up to 52 Weeks in Subjects With Moderate to Severe Facial Erythema Associated With Rosacea

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A long-term, open-label, non-comparative safety and efficacy study of CD07805/47 gel 0.5% once daily in subjects with moderate to severe facial erythema associated with rosacea.

Study identification

NCT ID
NCT01318733
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Galderma R&D
Industry
Enrollment
449 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2011 (Type not available)
Primary completion
Jun 2012 (Actual)
Completion
Jul 2012 (Actual)
Last update posted
Feb 18, 2021

2011 – 2012

United States locations

U.S. sites
27
U.S. states
17
U.S. cities
25
Facility City State ZIP Site status
The Laser Institute for Dermatology Santa Monica California 90404 —
Cherry Creek Research, Inc Denver Colorado 80209 —
Longmont Clinical PC Longmont Colorado 80501 —
Gwinnett Clinical Research Center, Inc Snellville Georgia 30078 —
Deaconess Clinic Evansville Indiana 47713 —
Compliant Clinical Research Olathe Kansas 66061 —
Hamzavi Dermatology Fort Gratiot Michigan 48059 —
Dermcenter PC- Somerset Skin Centre Troy Michigan 48084 —
Minnesota Clinical Study Center Fridley Minnesota 55432 —
Skin Specialists, PC Omaha Nebraska 68144 —
DermResearch Center of New York, Inc Stony Brook New York 11790 —
Metrolina Medical Research Charlotte North Carolina 27277 —
Dermatology, Laser & Vein Specialists of the Carolinas Charlotte North Carolina 28207 —
Wilmington Medical Research Wilmington North Carolina 28401 —
Piedmont Medical Research Winston-Salem North Carolina 27103 —
DermDox Hazleton Pennsylvania 18201 —
Palmetto Medical Research Mt. Pleasant South Carolina 29464 —
Rivergate Dermatology Clinical Research Center, PLLC Goodlettsville Tennessee 37072 —
East Tennessee Medical Research Johnson City Tennessee 37604 —
TriCities Medical Research Kingsport Tennessee 37660 —
Tennessee Clinical Research Center Nashville Tennessee 37215 —
Arlington Center for Dermatology Arlington Texas 76011 —
Dermatology Clinical Research Center of San Antonio San Antonio Texas 78229 —
Progressive Clinical Research, PA San Antonio Texas 78229 —
Dermatology Research Center Salt Lake City Utah 84124 —
Wenatchee Valley Medical Center - Clinical Research Department Wenatchee Washington 98801 —
Madison Skin & Research, Inc. Madison Wisconsin 53719 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01318733, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 18, 2021 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01318733 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →